These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23681957)

  • 1. Nonfitting protein-ligand interaction scoring function based on first-principles theoretical chemistry methods: development and application on kinase inhibitors.
    Rao L; Zhang IY; Guo W; Feng L; Meggers E; Xu X
    J Comput Chem; 2013 Jul; 34(19):1636-46. PubMed ID: 23681957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferable scoring function based on semiempirical quantum mechanical PM6-DH2 method: CDK2 with 15 structurally diverse inhibitors.
    Dobeš P; Fanfrlík J; Rezáč J; Otyepka M; Hobza P
    J Comput Aided Mol Des; 2011 Mar; 25(3):223-35. PubMed ID: 21286784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing limitations with the MM-GB/SA scoring procedure using the WaterMap method and free energy perturbation calculations.
    Guimarães CR; Mathiowetz AM
    J Chem Inf Model; 2010 Apr; 50(4):547-59. PubMed ID: 20235592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of various electrostatic potentials on docking precision against cyclin-dependent kinase 2 protein: a multiple docking approach.
    Tripathi SK; Soundarya RN; Singh P; Singh SK
    Chem Biol Drug Des; 2015 Feb; 85(2):107-18. PubMed ID: 24923208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New scoring functions for virtual screening from molecular dynamics simulations with a quantum-refined force-field (QRFF-MD). Application to cyclin-dependent kinase 2.
    Ferrara P; Curioni A; Vangrevelinghe E; Meyer T; Mordasini T; Andreoni W; Acklin P; Jacoby E
    J Chem Inf Model; 2006; 46(1):254-63. PubMed ID: 16426061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-novo: an automated workflow for efficient structure-based lead optimization.
    Pearce BC; Langley DR; Kang J; Huang H; Kulkarni A
    J Chem Inf Model; 2009 Jul; 49(7):1797-809. PubMed ID: 19552372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus scoring approach to identify the inhibitors of AMP-activated protein kinase α2 with virtual screening.
    Park H; Eom JW; Kim YH
    J Chem Inf Model; 2014 Jul; 54(7):2139-46. PubMed ID: 24915156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the structural basis of N2 and O6 substituted guanine derivatives as cyclin-dependent kinase 2 (CDK2) inhibitors: prediction of the binding modes and potency of the inhibitors by docking and ONIOM calculations.
    Alzate-Morales JH; Caballero J; Vergara Jague A; González Nilo FD
    J Chem Inf Model; 2009 Apr; 49(4):886-99. PubMed ID: 19323453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantum mechanical scoring: structural and energetic insights into cyclin-dependent kinase 2 inhibition by pyrazolo[1,5-a]pyrimidines.
    Brahmkshatriya PS; Dobeš P; Fanfrlik J; Rezáç J; Paruch K; Bronowska A; Lepšík M; Hobza P
    Curr Comput Aided Drug Des; 2013 Mar; 9(1):118-29. PubMed ID: 23157414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-docking of inhibitors into CDK2 structures. 1.
    Duca JS; Madison VS; Voigt JH
    J Chem Inf Model; 2008 Mar; 48(3):659-68. PubMed ID: 18324799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale validation of a quantum mechanics based scoring function: predicting the binding affinity and the binding mode of a diverse set of protein-ligand complexes.
    Raha K; Merz KM
    J Med Chem; 2005 Jul; 48(14):4558-75. PubMed ID: 15999994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprocessing of protein-ligand docking poses using linear response MM-PB/SA: application to Wee1 kinase inhibitors.
    Wichapong K; Lawson M; Pianwanit S; Kokpol S; Sippl W
    J Chem Inf Model; 2010 Sep; 50(9):1574-88. PubMed ID: 20712342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of allosteric inhibitors of p21-activated kinase.
    Viaud J; Peterson JR
    Methods Mol Biol; 2012; 928():67-79. PubMed ID: 22956134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Explicit treatment of active-site waters enhances quantum mechanical/implicit solvent scoring: Inhibition of CDK2 by new pyrazolo[1,5-a]pyrimidines.
    Hylsová M; Carbain B; Fanfrlík J; Musilová L; Haldar S; Köprülüoğlu C; Ajani H; Brahmkshatriya PS; Jorda R; Kryštof V; Hobza P; Echalier A; Paruch K; Lepšík M
    Eur J Med Chem; 2017 Jan; 126():1118-1128. PubMed ID: 28039837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge-based scoring functions in drug design. 1. Developing a target-specific method for kinase-ligand interactions.
    Xue M; Zheng M; Xiong B; Li Y; Jiang H; Shen J
    J Chem Inf Model; 2010 Aug; 50(8):1378-86. PubMed ID: 20681607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A computational model of binding thermodynamics: the design of cyclin-dependent kinase 2 inhibitors.
    Sims PA; Wong CF; McCammon JA
    J Med Chem; 2003 Jul; 46(15):3314-25. PubMed ID: 12852762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter space.
    Naïm M; Bhat S; Rankin KN; Dennis S; Chowdhury SF; Siddiqi I; Drabik P; Sulea T; Bayly CI; Jakalian A; Purisima EO
    J Chem Inf Model; 2007; 47(1):122-33. PubMed ID: 17238257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reliable docking/scoring scheme based on the semiempirical quantum mechanical PM6-DH2 method accurately covering dispersion and H-bonding: HIV-1 protease with 22 ligands.
    Fanfrlík J; Bronowska AK; Rezác J; Prenosil O; Konvalinka J; Hobza P
    J Phys Chem B; 2010 Oct; 114(39):12666-78. PubMed ID: 20839830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics, density functional, ADMET predictions, virtual screening, and molecular interaction field studies for identification and evaluation of novel potential CDK2 inhibitors in cancer therapy.
    da Silva VB; Kawano DF; Gomes Ada S; Carvalho I; Taft CA; da Silva CH
    J Phys Chem A; 2008 Sep; 112(38):8902-10. PubMed ID: 18698751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FURSMASA: a new approach to rapid scoring functions that uses a MD-averaged potential energy grid and a solvent-accessible surface area term with parameters GA fit to experimental data.
    Pearlman DA; Rao BG; Charifson P
    Proteins; 2008 May; 71(3):1519-38. PubMed ID: 18300249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.